A. Stone Douglass - 18 Jan 2023 Form 4 Insider Report for Hypha Labs, Inc. (FUNI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Dec 2024, 16:50:10 UTC
Prior SEC filing
22 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ A. Stone Douglass

Key filing fact

A. Stone Douglass filed Form 4 for Hypha Labs, Inc. (FUNI) on 02 Dec 2024.

Key facts

  • This page summarizes A. Stone Douglass's Form 4 filing for Hypha Labs, Inc. (FUNI).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Dec 2024, 16:50.

Change

  • Previous filing in this sequence was filed on 22 Oct 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FUNI transaction

Common Stock

Award

Transaction value
$0
Shares
+2,000,000
Change %
+133%
Price
$0.000000
Shares after
3,500,000
Date
18 Jan 2023
Ownership
Direct
Footnotes
F1, F2
FUNI transaction

Common Stock

Award

Transaction value
$0
Shares
+4,000,000
Change %
+114%
Price
$0.000000
Shares after
7,500,000
Date
29 Feb 2024
Ownership
Direct
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This Form 4 is being filed late due to an administrative error.

Footnote F2

Represents a grant of the issuer's common stock to the reporting person for services performed in connection with work related to the issuer's sale of Digipath Labs, Inc.

Footnote F3

Represents a grant of the issuer's common stock to the reporting person in connection with the reporting person's appointment as President and Chief Executive Officer of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .